Indaptus Therapeutics Financial Overview
Indaptus Therapeutics's market cap is currently $4.47M. The company's EPS TTM is $-2.98; its P/E ratio is -0.08; Indaptus Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-4.36. See an overview of income statement, balance sheet, and cash flow financials.
